3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
233
Lung Neoplasms
96
Adenocarcinoma of Lung
39
Colorectal Neoplasms
21
Adenocarcinoma, Bronchiolo-Alveolar
19
Neoplasms
18
Small Cell Lung Carcinoma
13
Non-Squamous Non-Small Cell Lung Cancer
13
Brain Neoplasms
13
Neoplasm Metastasis
10
Ovarian Neoplasms
9
Pleural Effusion, Malignant
8
Breast Neoplasms
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Meningeal Carcinomatosis
7
Mesothelioma
6
Melanoma
6
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Rectal Neoplasms
4
Non-squamous Non-small Cell Lung Cancer
4
Carcinoma, Renal Cell
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Non-small Cell Lung Cancer Metastatic
3
Mesothelioma, Malignant
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Interventions
lorlatinib
3
pembrolizumab
2
osimertinib
2
Radiotherapy
2
atezolizumab
1
Temozolomide
1
Radiosurgery
1
Paclitaxel
1
Nivolumab
1
Ipilimumab
1
Fecal Microbiota Transplantation
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non Small Cell Lung Cancer Metastatic
×
Bevacizumab
×
Thoracic
×
Clear all
NCT03133546
2026-02-06
BOOSTER
ETOP IBCSG Partners Foundation
Phase 2
Completed
155 enrolled
23 charts